Interruptions of once-daily thoracic radiotherapy do not correlate with outcomes in limited stage small cell lung cancer: analysis of CALGB phase III trial 9235.

[1]  B. Jeremic,et al.  Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. , 2007, International journal of radiation oncology, biology, physics.

[2]  B. Jeremic,et al.  Pretreatment prognostic factors in patients with early-stage (I/II) non-small-cell lung cancer treated with hyperfractionated radiation therapy alone. , 2006, International journal of radiation oncology, biology, physics.

[3]  P. Lambin,et al.  Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  D. Ettinger,et al.  Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature? , 2005, Lung cancer.

[5]  B. Jeremic.  Patterns of care survey (PCS) in chemotherapy (CHT) in nonmetastatic lung cancer. , 2005, Lung cancer.

[6]  J. Herndon,et al.  A Phase III Trial Evaluating the Combination of Cisplatin, Etoposide, and Radiation Therapy With or Without Tamoxifen in Patients With Limited-Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Study (9235) , 2005, American journal of clinical oncology.

[7]  M. Socinski,et al.  Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  J. Herndon,et al.  70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808. , 2004, International journal of radiation oncology, biology, physics.

[9]  D. Ettinger,et al.  Radiotherapy patterns of care study in lung carcinoma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  N. Saijo,et al.  Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  L. Stitt,et al.  Using treatment interruptions to palliate the toxicity from concurrent chemoradiation for limited small cell lung cancer decreases survival and disease control. , 2001, Lung cancer.

[12]  J. Jett,et al.  Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  R. Komaki,et al.  Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. , 1999, The New England journal of medicine.

[14]  J. Damilakis,et al.  The impact of overall treatment time on the results of radiotherapy for nonsmall cell lung carcinoma. , 1996, International journal of radiation oncology, biology, physics.

[15]  J P Pignon,et al.  A meta-analysis of thoracic radiotherapy for small-cell lung cancer. , 1992, The New England journal of medicine.

[16]  P. Rubin,et al.  interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts new evidence for accelerated proliferation from radiation therapy oncology group protocol 8313 , 1992, Cancer.

[17]  M. Lindstrom,et al.  Loss of local control with prolongation in radiotherapy. , 1992, International journal of radiation oncology, biology, physics.

[18]  W. Curran,et al.  Elapsed treatment days--a critical item for radiotherapy quality control review in head and neck trials: RTOG report. , 1991, International journal of radiation oncology, biology, physics.

[19]  P. Warde,et al.  Does thoracic irradiation improve survival and local control in limited stage small cell carcinoma of the lung - A meta-analysis , 1990 .